JRCT ID: jRCT2080224882
Registered date:20/09/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 09/10/2019 |
Target sample size | 10 |
Countries of recruitment | Asia except Japan,North America,Japan,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 392 Antidotes Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy pharmacokinetics safety |
Key inclusion & exclusion criteria
Age minimum | >= 12age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03403205,JapicCTI-194967 |
Contact
Public contact | |
Name | |
Address | |
Telephone | +1-855-752-2356 |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | +1-855-752-2356 |
Affiliation |